Table 1.
Pathology | Evolution in Pregnancy | ANOs and Complications |
---|---|---|
SLE | Worsens | Miscarriage, foetal death, prematurity, IUGR, neonatal lupus, CHB, preeclampsia, and C-section. |
RA | Improves in pregnancy, worsens in postpartum | Prematurity, IUGR, C-section, neonatal lupus, and CHB |
SpA | Improves in pregnancy, worsens in postpartum | Prematurity, IUGR, and C-section |
APS | Irrelevant, depends on aPL | Miscarriage, foetal death, prematurity, IUGR, preeclampsia, and C-section |
SS | Irrelevant | Prematurity, IUGR, C-section, neonatal lupus, and CHB |
UCTD | According to clinical status | Miscarriage, foetal death, prematurity, IUGR, neonatal lupus, CHB, preeclampsia, and C-section |
HT | Irrelevant, depends on mutation | Miscarriage, foetal death, prematurity, IUGR, preeclampsia and C-section |
Adverse neonatal outcomes (ANOs), rheumatic diseases (RD), hereditary thrombophilia (HT), systemic lupus erythematosus (SLE), intrauterine growth retarded (IUGR), Caesarean section (C-section), neonatal lupus, congenital heart block (CHB), rheumatoid arthritis (RA), spondyloarthritis (SpA), antiphospholipid syndrome (APS), antiphospholipid (aPL) antibodies, Sjögren syndrome (SS), undifferentiated connective tissue disease (UCTD). Taken from 6, 18.